NCT01768923View on ClinicalTrials.gov

Early RA Vascular Randomised Controlled Study

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Early Rheumatoid Arthritis
Interventions
PROCEDURE

SDAI remission

SDAI remission group aims at the 2011 ACR/EILAR definition of remission (simplified disease activity score \[SDAI\] \<3.3)

PROCEDURE

Minimal disease activity remission

Minimal disease activity group aims at minimal disease activity (DAS28\<2.6) (minimal disease activity group)

Trial Locations (1)

Unknown

Prince of Wales Hospital, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT01768923 - Early RA Vascular Randomised Controlled Study | Biotech Hunter | Biotech Hunter